Skip to main content
Mark Vandewalker, MD, Allergy & Immunology, Columbia, MO

MarkLewisVandewalkerMD

Allergy & Immunology Columbia, MO

Asthma & Allergic Conditions, Pediatric Asthma & Allergic Conditions

Private Practice Allergist and Medical Director for Clinical Research of the Ozarks

Dr. Vandewalker is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Vandewalker's full profile

Already have an account?

Summary

  • I am a BC allergist in specialty practice for almost 40 years in mid-Missouri. In addition to part-time employment with Family Allergy and Asthma of Louisville, I serve as Medical Director for Clinical Research of the Ozarks. We have conducted over 500 clinical trials of new allergy and asthma drugs during three decades. I teach outpatient allergy/asthma management skills to medical students and residents who rotate through my office. I consult and speak for several pharma companies and have been privileged to serve my specialty in leadership at state and national levels. I plan to fund a research grant in Allergy/Immunology at St Louis U. School of Medicine, my alma mater.

Education & Training

  • Fitzsimons Army Medical Center
    Fitzsimons Army Medical CenterFellowship, Allergy and Immunology, 1983 - 1985
  • Fitzsimons Army Medical Center
    Fitzsimons Army Medical CenterResidency, Pediatrics, 1978 - 1981
  • Saint Louis University School of Medicine
    Saint Louis University School of MedicineClass of 1978

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 1985 - 2025
  • American Board of Allergy and Immunology Allergy & Immunology
  • American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • Fellow, American College of Allergy, Asthma, and Immunology ACAAI, 1986
  • Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology

Publications & Presentations

PubMed

Press Mentions

  • New Analyses: Adding SPIRIVA® Respimat® Effective for Uncontrolled Asthma – Regardless of Allergy Subtype1,2,3
    New Analyses: Adding SPIRIVA® Respimat® Effective for Uncontrolled Asthma – Regardless of Allergy Subtype1,2,3March 8th, 2016

Research History

  • Medical Director/Principal InvestigatorI have conducted over 500 FDA-reviewed clinical trials involving allergic rhinitis, asthma, allergic conjunctivitis, chronic urticaria, COPD, and pharmacokinetic studies.1990 - Present

Professional Memberships